An intrinsic DFF40/CAD endonuclease deficiency impairs oligonucleosomal DNA hydrolysis during caspase-dependent cell death: a common trait in human glioblastoma cells.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neuro-Oncology

• Publication date

  2016-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/neuonc/nov315PMID 26755073PMCID PMC4896542
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An Early and Robust Activation of Caspases Heads Cells for a Regulated Form of Necrotic-like Cell Death*

  2015cited by this paper
• Glioma in 2014: Unravelling tumour heterogeneity—implications for therapy

  2015cited by this paper
• Molecular subtypes, stem cells and heterogeneity: Implications for personalised therapy in glioma.

  2015cited by this paper
• Personalized Medicine for Gliomas

  2015cited by this paper
• Oxidized extracellular DNA as a stress signal that may modify response to anticancer therapy.

  2015cited by this paper
• Rethinking glioma treatment strategy

  2014cited by this paper
• Caspase-activated DNase Is Necessary and Sufficient for Oligonucleosomal DNA Breakdown, but Not for Chromatin Disassembly during Caspase-dependent Apoptosis of LN-18 Glioblastoma Cells*

  2014cited by this paper
• Old, new and emerging functions of caspases

  2014cited by this paper
• ICAD Deficiency in Human Colon Cancer and Predisposition to Colon Tumorigenesis: Linkage to Apoptosis Resistance and Genomic Instability

  2013cited by this paper
• Nuclear karyopherin a2: a novel biomarker for infiltrative astrocytomas

  2012cited by this paper
• Apoptotic DNA Degradation into Oligonucleosomal Fragments, but Not Apoptotic Nuclear Morphology, Relies on a Cytosolic Pool of DFF40/CAD Endonuclease*

  2012cited by this paper
• CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

  2012cited by this paper
• Activation of p53 by Nutlin-3a Induces Apoptosis and Cellular Senescence in Human Glioblastoma Multiforme

  2011cited by this paper
• Copy Number Alterations in Glioma Cell Lines

  2011cited by this paper
• GFAP in health and disease.

  2011cited by this paper
• Prognostic Value of Free DNA Quantification in Serum and Cerebrospinal Fluid in Glioma Patients

  2011cited by this paper
• Abstract 808: Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology

  2010cited by this paper
• Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas

  2010cited by this paper
• Infiltrating CTLs in human glioblastoma establish immunological synapses with tumorigenic cells.

  2009cited by this paper
• Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma.

  2007cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• WHO classification of tumours of the central nervous system

  2007cited by this paper
• Sequence Elements in Both Subunits of the DNA Fragmentation Factor Are Essential for Its Nuclear Transport*

  2007cited by this paper
• Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

  2006cited by this paper
• A unique role of the DNA fragmentation factor in maintaining genomic stability

  2006cited by this paper
• Apoptotic DNA fragmentation factor maintains chromosome stability in a P53-independent manner

  2006cited by this paper
• 'Pseudopalisading' Necrosis in Glioblastoma: A Familiar Morphologic Feature That Links Vascular Pathology, Hypoxia, and Angiogenesis

  2006cited by this paper
• In vivo mature immunological synapses forming SMACs mediate clearance of virally infected astrocytes from the brain

  2006cited by this paper
• Trashing the genome: the role of nucleases during apoptosis

  2005cited by this paper
• Applying the principles of stem-cell biology to cancer

  2003cited by this paper
• Necrosis and Glioblastoma: A Friend or a Foe? A Review and a Hypothesis

  2002cited by this paper
• Chk2 Is a Tumor Suppressor That Regulates Apoptosis in both an Ataxia Telangiectasia Mutated (ATM)-Dependent and an ATM-Independent Manner

  2002cited by this paper
• The Absence of Oligonucleosomal DNA Fragmentation during Apoptosis of IMR-5 Neuroblastoma Cells

  2001cited by this paper
• The development of necrosis and apoptosis in glioma: experimental findings using spheroid culture systems*

  2001cited by this paper
• Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice

  2001cited by this paper
• DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation

  2000cited by this paper
• Genomic instability in Gadd45a-deficient mice

  1999cited by this paper
• A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD

  1998cited by this paper
• The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis.

  1998cited by this paper
• Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis

  1998cited by this paper
• DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis.

  1997cited by this paper
• Characterization of the cell death process induced by staurosporine in human neuroblastoma cell lines.

  1997cited by this paper
• A review of human cell radiosensitivity in vitro.

  1996cited by this paper
• Cytogenetics of malignant gliomas: I. The autosomes with reference to rearrangements.

  1995cited by this paper

• A Mussel-Inspired Bioadhesive Patch to Selectively Kill Glioblastoma Cells.

  2026cites this paper
• Reaching the point-of-no-return: The cornerstone of glioblastoma treatment?

  2025cites this paper
• CAD hijacks STING to impair antitumor immunity and radiotherapy efficacy of colorectal cancer

  2025cites this paper
• DNA fragmentation factor 40-based therapeutic approaches for cancer: a review article

  2024cites this paper
• Production of recombinant DNA fragmentation factor 40 in fusion to an antimicrobial peptide from spider venom and evaluation of its cytotoxic effects

  2024cites this paper
• Temozolomide, Procarbazine and Nitrosoureas in the Therapy of Malignant Gliomas: Update of Mechanisms, Drug Resistance and Therapeutic Implications

  2023cites this paper
• The dual role of the CD95 and CD95L signaling pathway in glioblastoma

  2022cites this paper
• DFF40-iRGD, a novel chimeric protein with efficient cytotoxic and apoptotic effects against triple-negative breast cancer cells

  2021cites this paper
• The role of the DFF40/CAD endonuclease in genomic stability

  2021cites this paper
• DFF40 deficiency in cancerous T cells is implicated in chemotherapy drug sensitivity and resistance through the regulation of the apoptotic pathway.

  2021cites this paper
• Gossypol Treatment Restores Insufficient Apoptotic Function of DFF40/CAD in Human Glioblastoma Cells

  2021influential citation
• Energetic metabolic reprogramming in Jurkat DFF40-deficient cancer cells

  2021influential citation
• Design and characterization of a recombinant immunotoxin for targeted therapy of breast cancer cells: In vitro and in silico analyses.

  2020cites this paper
• La inactivación de Pim quinasas potencia la muerte celular mediada por el ligando de muerte trail en glioblastoma

  2019cites this paper
• PIM kinases mediate resistance of glioblastoma cells to TRAIL by a p62/SQSTM1-dependent mechanism

  2019cites this paper
• Two Simple Methods for Optimizing the Production of "Difficult-to-Express" GnRH-DFF40 Chimeric Protein

  2019cites this paper
• DNA FRAGMENTATION FACTOR 40 EXPRESSION IN T CELLS CONFER SENSIBILITY TO TRIBUTYLTIN-INDUCED APOPTOSIS.

  2019cites this paper
• Autonomic nervous system and cancer

  2018cites this paper
• The caspase‐activated DNase: apoptosis and beyond

  2017cites this paper
• DNA fragmentation factors 40 and 45 (DFF40/DFF45) and B-cell lymphoma 2 (Bcl-2) protein are underexpressed in uterine leiomyosarcomas and may predict survival

  2017cites this paper
• 1 The Normal Human Endometrium but not 2 Myometrium Presents Menstrual Cycle-Dependent 3 Fluctuations in the Immunoexpression of DNA 4 Fragmentation Factor 40 , DNA Fragmentation Factor 5 45 , and B-cell Lymphoma 2 Protein . 6

  2017cites this paper
• Immunoexpression of DNA fragmentation factor 40, DNA fragmentation factor 45, and B-cell lymphoma 2 protein in normal human endometrium and uterine myometrium depends on menstrual cycle phase and menopausal status

  2017cites this paper